Volitionrx (VNRX) Capital Expenditures (2011 - 2025)
Volitionrx (VNRX) posted Capital Expenditures of $10967.0 for Q4 2025, down 85.72% on a QoQ basis from $76783.0 in Q2 2025, and down 84.89% year-over-year from $72601.0 in Q4 2024.
Volitionrx (VNRX) Capital Expenditures (2011 - 2025) Analysis & Trends
Volitionrx's Capital Expenditures history runs 15 years deep, the most recent figure standing at $10967.0 for Q4 2025.
- Quarterly Capital Expenditures fell 84.89% year-over-year to $10967.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $89558.0 (down 67.73% YoY) and the FY2025 annual result came in at $89558.0, down 67.73% from the prior year.
- Capital Expenditures was $10967.0 for Q4 2025 at Volitionrx, down from $76783.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $578752.0 in Q4 2022 and bottomed at -$501986.0 in Q3 2023.
- A 5-year average of $171223.4 and a median of $128572.0 in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures jumped 350.14% — and 2023, when it plunged 254.23%.
- Volitionrx's Capital Expenditures stood at $128572.0 in 2021, then soared by 350.14% to $578752.0 in 2022, then plunged by 186.74% to -$501986.0 in 2023, then jumped by 114.46% to $72601.0 in 2024, then sank by 84.89% to $10967.0 in 2025.
- Business Quant data shows VNRX's Capital Expenditures at $10967.0 in Q4 2025, $76783.0 in Q2 2025, and $1808.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 10,967.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,967.00 |
| Dec 31, 2025 | 10,967.00 |
| Jun 30, 2025 | 76,783.00 |
| Jun 30, 2025 | 76,783.00 |
| Mar 31, 2025 | 1,808.00 |
| Mar 31, 2025 | 1,808.00 |
| Dec 31, 2024 | 72,601.00 |
| Dec 31, 2024 | 72,601.00 |
| Sep 30, 2024 | 136,737.00 |
| Sep 30, 2024 | 136,737.00 |
| Jun 30, 2024 | 18,161.00 |
| Jun 30, 2024 | 18,161.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Sep 30, 2023 | -501,986.00 |
| Sep 30, 2023 | -501,986.00 |
| Jun 30, 2023 | 501,986.00 |
| Jun 30, 2023 | 501,986.00 |
| Dec 31, 2022 | 578,752.00 |
| Dec 31, 2022 | 578,752.00 |